These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32075697)

  • 1. Carbapenemase-producing Enterobacteriaceae circulating in the Reunion Island, a French territory in the Southwest Indian Ocean.
    Miltgen G; Cholley P; Martak D; Thouverez M; Seraphin P; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Cimon CB; Ramiandrisoa M; Picot S; Lignereux A; Masson G; Allyn J; Allou N; Mavingui P; Belmonte O; Bertrand X; Hocquet D
    Antimicrob Resist Infect Control; 2020 Feb; 9(1):36. PubMed ID: 32075697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of carbapenemase-producing Enterobacteriaceae in the Indian Ocean Region between January 2010 and December 2015.
    Holman AM; Allyn J; Miltgen G; Lugagne N; Traversier N; Picot S; Lignereux A; Oudin C; Belmonte O; Allou N
    Med Mal Infect; 2017 Sep; 47(5):333-339. PubMed ID: 28602387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
    Miltgen G; Bonnin RA; Avril C; Benoit-Cattin T; Martak D; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Filleul L; Subiros M; de Montera AM; Cholley P; Thouverez M; Dortet L; Bertrand X; Naas T; Hocquet D; Belmonte O
    Int J Antimicrob Agents; 2018 Sep; 52(3):416-420. PubMed ID: 29807164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
    Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
    Lefebvre B; Lévesque S; Bourgault AM; Mulvey MR; Mataseje L; Boyd D; Doualla-Bell F; Tremblay C
    PLoS One; 2015; 10(4):e0125076. PubMed ID: 25910041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea.
    Park JW; Lee H; Park SY; Kim TH
    Antimicrob Resist Infect Control; 2019; 8():48. PubMed ID: 30873279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals.
    Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M
    Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).
    Österblad M; Kirveskari J; Hakanen AJ; Tissari P; Vaara M; Jalava J
    J Antimicrob Chemother; 2012 Dec; 67(12):2860-4. PubMed ID: 22855858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
    Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
    J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of β-Lactamase Resistance Determinants in Enterobacteriaceae from Chicago Children: a Multicenter Survey.
    Logan LK; Hujer AM; Marshall SH; Domitrovic TN; Rudin SD; Zheng X; Qureshi NK; Hayden MK; Scaggs FA; Karadkhele A; Bonomo RA
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3462-9. PubMed ID: 27021322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
    Kumudunie WGM; Wijesooriya LI; Namalie KD; Sunil-Chandra NP; Wijayasinghe YS
    J Infect Public Health; 2020 Sep; 13(9):1330-1335. PubMed ID: 32439355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013.
    Ohno Y; Nakamura A; Hashimoto E; Matsutani H; Abe N; Fukuda S; Hisashi K; Komatsu M; Nakamura F
    J Infect Chemother; 2017 Apr; 23(4):224-229. PubMed ID: 28161293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
    Vlek AL; Frentz D; Haenen A; Bootsma HJ; Notermans DW; Frakking FN; de Greeff SC; Leenstra T;
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1089-96. PubMed ID: 27126332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominance of IMP-4-producing enterobacter cloacae among carbapenemase-producing Enterobacteriaceae in Australia.
    Sidjabat HE; Townell N; Nimmo GR; George NM; Robson J; Vohra R; Davis L; Heney C; Paterson DL
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4059-66. PubMed ID: 25918153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012-2018.
    Räisänen K; Lyytikäinen O; Kauranen J; Tarkka E; Forsblom-Helander B; Grönroos JO; Vuento R; Arifulla D; Sarvikivi E; Toura S; Jalava J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1651-1656. PubMed ID: 32307627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Hrabák J; Študentová V; Jakubů V; Adámková V; Dvořáková L; Balejova M; Bergerová T; Chmelařová E; Ježek P; Kabelíková P; Kolář M; Paterová P; Tejkalová R; Papagiannitsis C; Žemličková H
    Epidemiol Mikrobiol Imunol; 2015 Jun; 64(2):87-91. PubMed ID: 26099612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.